以癌症治疗为重点的ORIC制药公司将在J. P. Morgan保健大会上发言。 ORIC Pharmaceuticals, focusing on cancer treatments, to present at J.P. Morgan Healthcare Conference.

ORIC制药公司是一家开发治疗抗药性癌症治疗的公司,将于2025年1月14日出席J.P.Morgan保健大会。 ORIC Pharmaceuticals, a company developing cancer treatments for therapeutic resistance, will present at the J.P. Morgan Healthcare Conference on January 14, 2025. CEO Jacob M. Chacko将提供一份概览,将进行现场网播,并在公司网站上进行90天的重播。 CEO Jacob M. Chacko will give an overview, which will be live webcast and available for replay on the company's website for 90 days. 欧理会侧重于精准药物,以改善癌症患者的治疗结果。 ORIC focuses on precision medicines to improve outcomes in cancer patients.